Toward Equitable Access to Psychosocial Screening in Canada: Validation of the French–Canadian Psychosocial Assessment Tool
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.31501 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Émilie Trudel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departement of Psychology, Université de Montréal, Montréal, Québec, Canada. Hauptthemen laut MEDLINE: Neoplasms, Caregivers, Health Services Accessibility, Parents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Objective
The Psychosocial Assessment Tool (PAT) is a brief caregiver report, family‐centered, psychosocial risk screening tool widely used in pediatrics and available in many languages. Although French is an official language of Canada, a French–Canadian version of the PAT has not yet been validated, which impedes access to this tool for family psychosocial screening. This study aimed to translate, adapt as necessary, and validate the French–Canadian version of the PAT.
Methods
The PAT 3.0 was translated into French using the forward–backwards method. Interviews with healthcare workers ( n = 5) and a focus group of parents of children newly diagnosed with cancer ( n = 4) led to minor modifications to improve cultural adaptation and comprehensibility. Subsequently, 66 French‐speaking parents of children newly diagnosed with cancer participated in a quantitative validation study; completing the French–Canadian PAT and related caregiver measures.
Results
The French–Canadian PAT has an overall internal consistency of KR‐20 = 0.64, with subscales ranging from 0.57 to 0.86. The total PAT score significantly correlated with the Distress Thermometer ( r = 0.54). Congruent validity was demonstrated for most PAT subscales, except for Family Beliefs and Family Problems. The sample followed this distribution on the Pediatric Psychosocial Preventative Health Model: 21.2% universal , 53% targeted , and 25.8% clinical .
Conclusion
The French–Canadian PAT provides insight into family psychosocial risk. This study is a step toward equitable access to care by providing French‐speaking families with access to a tool aligned with the psychosocial standards of care in pediatric oncology. Future research should focus on implementing the PAT in Canadian clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departement of Psychology, Université de Montréal, Montréal, Québec, Canada.
- Azrieli Research Centre, Centre Hospitalier Universitaire Sainte-Justine, Montréal, Québec, Canada.
- Department of Anesthesiology and Medical Medicine, Université de Montréal, Montreal, Québec, Canada.
- Maisonneuve-Rosemont Hospital, Montréal, Québec, Canada.
- Department of Pediatrics, Université de Montréal, Montreal, Québec, Canada.
ORCID-Profile: Émilie Trudel, Serge Sultan
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Trudel, É., Ogez, D., Sultan, S., Brunier, L. S., Bernier, P., Charrette, M. C., Rondeau, É., & Desjardins, L. (2025). Toward Equitable Access to Psychosocial Screening in Canada: Validation of the French–Canadian Psychosocial Assessment Tool. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31501
Vancouver
Trudel É, Ogez D, Sultan S, Brunier LS, Bernier P, Charrette MC, et al. Toward Equitable Access to Psychosocial Screening in Canada: Validation of the French–Canadian Psychosocial Assessment Tool. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31501
BibTeX
@article{Trudel2025,
author = {Trudel, Émilie and Ogez, David and Sultan, Serge and Brunier, Lisa-Sarah and Bernier, Pascal and Charrette, Marie-Claude and Rondeau, Émélie and Desjardins, Leandra},
title = {Toward Equitable Access to Psychosocial Screening in Canada: Validation of the French–Canadian Psychosocial Assessment Tool},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.31501}
}
EUVIMED